Literature DB >> 15205994

Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene.

Katalin Balogh1, Attila Patócs1, Judit Majnik1, Fatima Varga2, György Illyés3, László Hunyady4, Károly Rácz5.   

Abstract

We report an unusual presentation of multiple endocrine neoplasia type 1 (MEN 1) in a young woman who was subsequently proven to have a novel mutation of the MEN1 gene. The young patient, aged 25 years, was investigated for abdominal discomfort and left upper abdominal pain. Her family history was unremarkable, except an unknown disorder of her father causing early death. Abdominal ultrasonography (USG) and computed tomography revealed a giant pancreatic tumor measuring 10 cm in diameter. The diagnosis of a clinically nonfunctioning pancreatic neuroendocrine tumor was established by clinical and other studies, including USG-guided aspiration biopsy and octreotide scintigraphy, and the patient underwent a distal pancreatectomy. Histology proved a well-differentiated multinodular neuroendocrine tumor of the pancreas. During surgery, a subcutaneous lipoma was also removed from the abdominal wall. Two years later, the patient developed primary hyperparathyroidism, and two enlarged parathyroid glands were surgically removed. Magnetic resonance imaging of the pituitary gland was normal. Screening for MEN1 gene mutation by temperature gradient gel electrophoresis revealed heterozygosities in exons 3, 8, and 9, while direct sequencing indicated a novel germline mutation (C354X) resulting in a stop codon in exon 8 and polymorphisms in exon 3 (R171Q) and exon 9 (D418D and L432L). Genetic screening revealed no mutation in living family members. Our unusual case suggests that a multinodular pancreatic neuroendocrine tumor in a young patient may justify screening for MEN 1 syndrome, even in the absence of other endocrinopathy or family history.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205994     DOI: 10.1007/s10038-004-0163-2

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  25 in total

1.  Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.

Authors:  H Kaji; L Canaff; J J Lebrun; D Goltzman; G N Hendy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  MEN1 gene mutation analysis of sporadic adrenocortical lesions.

Authors:  B Görtz; J Roth; E J Speel; A Krähenmann; R R De Krijger; X Matias-Guiu; S Muletta-Feurer; K Rütmann; P Saremaslani; P U Heitz; P Komminoth
Journal:  Int J Cancer       Date:  1999-01-29       Impact factor: 7.396

3.  Giant insulinoma in a patient with multiple endocrine neoplasia-type I: a case report.

Authors:  H Kataoka; F Otsuka; T Yamauchi; M Kishida; M Takahashi; T Tamiya; Y Mimura; T Ogura; H Makino
Journal:  Endocr J       Date:  1999-06       Impact factor: 2.349

Review 4.  Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.

Authors:  S S Guo; M P Sawicki
Journal:  Mol Endocrinol       Date:  2001-10

5.  Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Authors:  E Edström; E Mahlamäki; B Nord; M Kjellman; R Karhu; A Höög; N Goncharov; B T Teh; M Bäckdahl; C Larsson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

Authors:  D Trump; B Farren; C Wooding; J T Pang; G M Besser; K D Buchanan; C R Edwards; D A Heath; C E Jackson; S Jansen; K Lips; J P Monson; D O'Halloran; J Sampson; S M Shalet; M H Wheeler; A Zink; R V Thakker
Journal:  QJM       Date:  1996-09

7.  A rapid and easy method for multiple endocrine neoplasia type 1 mutation detection using conformation-sensitive gel electrophoresis.

Authors:  Cebrián Arancha; Sergio Ruíz-Llorente; Alberto Cascón; Ana Osorio; Beatriz Martínez-Delgado; Javier Benítez; Mercedes Robledo
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

8.  Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.

Authors:  Hiroko Yaguchi; Naganari Ohkura; Toshihiko Tsukada; Ken Yamaguchi
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

9.  Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.

Authors:  E Baudin; J M Bidart; P Rougier; V Lazar; P Ruffié; J Ropers; M Ducreux; F Troalen; J C Sabourin; E Comoy; P Lasser; T DeBaere; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.

Authors:  J-H Park; I-J Kim; H C Kang; S-H Lee; Y Shin; K-H Kim; S-B Lim; S-B Kang; Ku Lee; S Y Kim; M-S Lee; M-K Lee; J-H Park; S-D Moon; J-G Park
Journal:  Clin Genet       Date:  2003-07       Impact factor: 4.438

View more
  1 in total

1.  True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.

Authors:  Annamária Kövesdi; Miklós Tóth; Henriett Butz; Nikolette Szücs; Beatrix Sármán; Péter Pusztai; Judit Tőke; Péter Reismann; Mónika Fáklya; Géza Tóth; Anikó Somogyi; Katalin Borka; Annamária Erdei; Endre V Nagy; Veronika Deák; Zsuzsanna Valkusz; Péter Igaz; Attila Patócs; Vince Kornél Grolmusz
Journal:  Endocrine       Date:  2019-05-01       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.